An attempt to optimize the outcome of penetrating keratoplasty in congenital aniridia-associated keratopathy (AAK)
Open Access
- 29 July 2021
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 41 (12) , 4091-4098
Abstract
Purpose: To propose an optimized microsurgical and medical approach to reduce the risk of complications after penetrating keratoplasty (PKP) in patients with aniridia-associated keratopathy (AAK).Methods: Retrospective observational case series of 25 PKP performed in 16 patients with AAK. Preoperative indications were endothelial decompensation and vascularized scars (68%) or graft failure (32%) due to limbal stem cell deficiency. The optimized approach included a combination of a small corneal graft size (around 7.0 mm), interrupted 10–0nylon sutures, simultaneous AMT as a patch, large bandage contact lens, temporary lateral tarsorrhaphy, postoperative autologous serum eye drops, and systemic immunosuppression. Main outcome measures included: visual acuity, transplant survival, and complications encountered during follow-up of 107 weeks on average.Results: A complete modified keratoplasty scheme was used in 10 of 25 PKP (group 1), while at least one of the modifications was missing in the other 15 PKP (group 2). After 8 weeks of follow-up, the epithelium was closed in 23 eyes. Visual acuity improved in 19 eyes at 6 months of follow-up, and remained stable in six eyes. None of the eyes showed a decrease in visual acuity. At the last post-operative follow-up, this visual improvement persisted in 14 eyes and graft survival rate after 156 weeks (3 years) was 69% in group 1 versus 44% in group 2 (p = 0.39, log-rank test). Secondary corneal neovascularization (8%), scarring (4%), ulcer (4%), or graft rejection (8%) happened mostly in the second group which was missing at least one of the suggested modifications.Conclusions: PKP in congenital aniridia must be considered as a high-risk keratoplasty. An optimized therapeutic approach seems to be promising in order to reduce the postoperative complication rate in these most difficult eyes.Keywords
All Related Versions
Funding Information
- Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
This publication has 33 references indexed in Scilit:
- Surgical and Visual Outcomes of the Type I Boston Keratoprosthesis for the Management of Aniridic Fibrosis Syndrome in Congenital AniridiaAmerican Journal of Ophthalmology, 2012
- Simultaneous Amniotic Membrane Patch in High-risk KeratoplastyCornea, 2011
- Aniridia: current pathology and managementActa Ophthalmologica, 2008
- Autologous Serum Eyedrops in the Treatment of Aniridic KeratopathyOphthalmology, 2008
- Outcomes of Boston Keratoprosthesis in Aniridia: A Retrospective Multicenter StudyAmerican Journal of Ophthalmology, 2007
- Integration Patterns of Cryopreserved Amniotic Membranes into the Human CorneaOphthalmology, 2006
- Histopathology and Ultrastructure of Human Corneas After Amniotic Membrane TransplantationArchives of Ophthalmology (1950), 2006
- Evolving concepts on the pathogenic mechanisms of aniridia related keratopathyThe International Journal of Biochemistry & Cell Biology, 2005
- Markedly increased central corneal thickness: an unrecognized finding in congenital aniridiaAmerican Journal of Ophthalmology, 2004
- The human PAX6 gene is mutated in two patients with aniridiaNature Genetics, 1992